Skip to main content


Healthcare Economist

ShafrinJason Shafrin, PhD, is a Director and Senior Research Economist at Precision Health Economics (PHE) in Los Angeles as well as the Director of Research at the Innovation and Value Initiative (IVI). The opinions expressed on this blog are only Jason’s and do not represent the opinions of PHE in any way.

Jason’s research interests include all issues related to healthcare policy and economics, value-based purchasing, the health insurance market, and Medicare policy research. For up to date information regarding Jason’s most recent research and contact information, please visit his homepage. You can view his published work on his Google Scholar page. Jason’s research has been published in a variety of peer-reviewed journals including JAMA, Health Affairs, Health Economics, Health Services Research, Value in Health, American Journal of Cardiology among others. In popular media, Dr. Shafrin has been interviewed by National Public Ratio (NPR), the Washington Times, and various trade journals and also has written articles for Forbes, the Health Affairs blog, STAT News, US News and World Report, and the Washington Post, among others.

Blog
October 09, 2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Blog
October 09, 2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles”…
Blog
July 06, 2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be…
Blog
May 26, 2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug…
Blog
May 20, 2020
Jason Shafrin, PhD, highlights a study that shows which factors payers consider when evaluating whether to provide…
Blog
March 04, 2020
Jason Shafrin, PhD, points to a recent study that shows clinical and cost effectiveness of a drug may improve over time…
Blog
February 14, 2020
Jason Shafrin, PhD, argues that clinician-directed performance improvement provides clear advantages, but payers are…
Blog
December 23, 2019
Jason Shafrin, PhD, sheds light on the challenge of quantifying the degree to which novel treatments address unmet need…
Blog
December 19, 2019
Jason Shafrin, PhD, argues that more evidence, tools, and physicians with expertise in treating older patients with…
Blog
December 11, 2019
Jason Shafrin, PhD, argues that, in most cases, efforts to improve quality measurement and keep pace with cancer…
Blog
October 08, 2019
Jason Shafrin, PhD, provides a description of the tools being created by health economists to quantify additional value…
Back to Top